Europe Serum Separation Gel Market Size, Share & Trends Analysis Report By Product Type (Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube), By End User, By Country and Growth Forecast, 2024 - 2031
The Europe Serum Separation Gel Market would witness market growth of 6.3% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $846 million by 2031. The UK market is exhibiting a CAGR of 5.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.2% during (2024 - 2031).
Continuous research and development efforts are focused on enhancing the performance of serum separation gel products. This includes improvements in gel formulations, tube designs, and manufacturing processes to achieve better separation efficiency, sample integrity, and compatibility with automated systems. Advancements in nanotechnology and biomaterials also influence the development of novel serum separation technologies.
Additionally, while serum separation gel has been the conventional method for separating serum from whole blood samples, there’s a growing trend toward gel-free separation methods. These methods rely on mechanical or physical barriers to separate serum from blood cells, eliminating the need for a gel barrier. Gel-free separation methods offer advantages such as faster processing times, reduced risk of gel-related interferences in assays, and compatibility with certain analytes or assays that may be affected by gel components.
The aging population in Europe is driving increased demand for senior healthcare services, including specialized care for older adults with chronic diseases and age-related health conditions. The aging of the European population is associated with an increased incidence of age-related and chronic illnesses, including diabetes, cancer, neurological disorders, and cardiovascular diseases. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- QuidelOrtho Corporation
By Product Type
- Serum Separation Gel Integrated with Tube
- Serum Separation Gel Integrated without Tube
- Blood Bank
- Hospital
- Pharmaceutical & Companies
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Serum Separation Gel Market, by Product Type
- 1.4.2 Europe Serum Separation Gel Market, by End User
- 1.4.3 Europe Serum Separation Gel Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. Europe Serum Separation Gel Market by Product Type
- 4.1 Europe Serum Separation Gel Integrated with Tube Market by Country
- 4.2 Europe Serum Separation Gel Integrated without Tube Market by Country
- Chapter 5. Europe Serum Separation Gel Market by End User
- 5.1 Europe Blood Bank Market by Country
- 5.2 Europe Hospital Market by Country
- 5.3 Europe Pharmaceutical & Companies Market by Country
- 5.4 Europe Others Market by Country
- Chapter 6. Europe Serum Separation Gel Market by Country
- 6.1 Germany Serum Separation Gel Market
- 6.1.1 Germany Serum Separation Gel Market by Product Type
- 6.1.2 Germany Serum Separation Gel Market by End User
- 6.2 UK Serum Separation Gel Market
- 6.2.1 UK Serum Separation Gel Market by Product Type
- 6.2.2 UK Serum Separation Gel Market by End User
- 6.3 France Serum Separation Gel Market
- 6.3.1 France Serum Separation Gel Market by Product Type
- 6.3.2 France Serum Separation Gel Market by End User
- 6.4 Russia Serum Separation Gel Market
- 6.4.1 Russia Serum Separation Gel Market by Product Type
- 6.4.2 Russia Serum Separation Gel Market by End User
- 6.5 Spain Serum Separation Gel Market
- 6.5.1 Spain Serum Separation Gel Market by Product Type
- 6.5.2 Spain Serum Separation Gel Market by End User
- 6.6 Italy Serum Separation Gel Market
- 6.6.1 Italy Serum Separation Gel Market by Product Type
- 6.6.2 Italy Serum Separation Gel Market by End User
- 6.7 Rest of Europe Serum Separation Gel Market
- 6.7.1 Rest of Europe Serum Separation Gel Market by Product Type
- 6.7.2 Rest of Europe Serum Separation Gel Market by End User
- Chapter 7. Company Profiles
- 7.1 Becton, Dickinson, and Company
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 F. Hoffmann-La Roche Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 SWOT Analysis
- 7.3 Abbott Laboratories
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 SWOT Analysis
- 7.4 Agilent Technologies, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Acquisition and Mergers:
- 7.4.6 SWOT Analysis
- 7.5 Siemens Healthineers AG (Siemens AG)
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Partnerships, Collaborations, and Agreements:
- 7.5.6 SWOT Analysis
- 7.6 Bio-Rad laboratories, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 Recent strategies and developments:
- 7.6.5.1 Partnerships, Collaborations, and Agreements:
- 7.6.5.2 Product Launches and Product Expansions:
- 7.6.6 SWOT Analysis
- 7.7 Danaher Corporation
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 SWOT Analysis
- 7.8 Sysmex Corporation
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 SWOT Analysis
- 7.9 Charles River Laboratories International, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 SWOT Analysis
- 7.10. QuidelOrtho Corporation
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expense
- 7.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook